Document:

Exhibit 10.15

 

THIS NOTE HAS NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE, AND
HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE
OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL FOR THE COMPANY
THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS.

 

THIS NOTE DOES NOT REQUIRE PHYSICAL SURRENDER
OF THIS NOTE IN THE EVENT OF A PARTIAL REDEMPTION OR CONVERSION. AS A RESULT, FOLLOWING ANY REDEMPTION OR CONVERSION OF ANY PORTION
OF THIS NOTE, THE OUTSTANDING PRINCIPAL AMOUNT REPRESENTED BY THIS NOTE MAY BE LESS THAN THE PRINCIPAL AMOUNT AND ACCRUED INTEREST
SET FORTH BELOW.

 

	Original Issue Date:  December 10, 2015	$110,000.00

 

NUGENE
INTERNATIONAL, INC.

 

10% CONVERTIBLE NOTE DUE DECEMBER 10,
2016

 

This 10% Convertible
Note of NUGENE INTERNATIONAL, INC., a Nevada corporation (the “Company”), having its principal place of business
at 17912 Cowan, Suite A, Irvine, California 92614 (this “Note”), is duly authorized and validly issued, and
is one of a series of notes designated the 10% Notes Due December 10, 2016. This Note is being issued with an original issue discount
of $10,000 for a purchase price of $100,000 (the “Purchase Price”).

 

FOR VALUE RECEIVED,
the Company promises to pay to the order of RBW, INC., a Cayman Islands company, or its registered assigns (the “Holder”),
or shall have paid pursuant to the terms hereunder, on or before December 10, 2016 (the “Maturity Date”) or
such earlier date as this Note is required or permitted to be repaid as provided hereunder, the principal sum of $110,000.00.

 

This Note is subject
to the following additional provisions:

 

Section 1.         Definitions.
 For the purposes hereof, in addition to the terms defined elsewhere in this Note (a) capitalized terms not otherwise defined
herein shall have the meanings set forth in the Purchase Agreement and (b) the following terms shall have the following meanings:

 

    	 	1	 

     

    

 

“Bankruptcy
Event” means any of the following events: (a) the Company or any Subsidiary thereof commences a case or other proceeding
under any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation
or similar law of any jurisdiction relating to the Company or any Subsidiary thereof; (b) there is commenced against the Company
or any Subsidiary thereof any such case or proceeding that is not dismissed within 60 days after commencement; (c) the Company
or any Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or
proceeding is entered; (d) the Company or any Subsidiary thereof suffers any appointment of any custodian or the like for it or
any substantial part of its property that is not discharged or stayed within 60 calendar days after such appointment; (e) the Company
or any Subsidiary thereof makes a general assignment for the benefit of creditors; (f) the Company or any Subsidiary thereof calls
a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts; or (g) the Company
or any Subsidiary thereof, by any act or failure to act, expressly indicates its consent to, approval of or acquiescence in any
of the foregoing or takes any corporate or other action for the purpose of effecting any of the foregoing.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which shall be a federal legal holiday in the United States
or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action
to close.

 

“Change
of Control Transaction” means the occurrence after the date hereof of any of (i) an acquisition after the date hereof
by an individual or legal entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Securities Exchange
Act of 1934, as amended) of effective control (whether through legal or beneficial ownership of capital stock of the Company, by
contract or otherwise) of in excess of 33% of the voting securities of the Company, or (ii) the Company merges into or consolidates
with any other entity, or any entity merges into or consolidates with the Company and, after giving effect to such transaction,
the stockholders of the Company immediately prior to such transaction own less than 66% of the aggregate voting power of the Company
or the successor entity of such transaction, or (iii) the Company sells or transfers all or substantially all of its assets to
a third party and the stockholders of the Company immediately prior to such transaction own less than 66% of the aggregate voting
power of the acquiring entity immediately after the transaction, or (iv) a replacement at one time or within a three year period
of more than one-half of the members of the Company’s board of directors which is not approved by a majority of those individuals
who are members of the board of directors on the date hereof (or by those individuals who are serving as members of the board of
directors on any date whose nomination to the board of directors was approved by a majority of the members of the board of directors
who are members on the date hereof), or (v) the execution by the Company of an agreement to which the Company is a party or by
which it is bound, providing for any of the events set forth in clauses (i) through (iv) above.

 

“Event
of Default” shall have the meaning set forth in Section 5.

 

“Fundamental
Transaction” means any Change of Control Transaction.

 

    	 	2	 

     

    

 

“Mandatory
Default Amount” is equal to the greater of (i) one hundred twenty percent (120%) of the outstanding principal (plus all
accrued and unpaid Interest, if any) and (ii) the product of (A) the highest closing price for the five (5) days on which the principal
Primary Market is open for business (a “Trading Day”) immediately preceding the Holder’s acceleration
and (B) a fraction, of which the numerator is the entire outstanding principal, and of which the denominator is the Conversion
Price as of the date such ratio is being determined.

 

“New
York Courts” shall have the meaning set forth in Section 7(d).

 

“Original
Issue Date” means the date of the issuance of this Note, regardless of any transfers of any Note and regardless of the
number of instruments which may be issued to evidence this Note.

 

“Purchase
Agreement” means that certain Securities Purchase Agreement, dated on or about the date hereof, among the Company
and the Holder, as amended, modified or supplemented from time to time in accordance with its terms.

 

“Subsidiary”
means any direct or indirect subsidiary of the Company currently existing or formed or acquired after the date hereof.

 

Section 2.        Interest
Rate; Default Interest.

 

a)          Interest
Rate. A one-time interest charge of 10% shall be applied on the Original Issue Date and shall be payable in cash on the Maturity
Date, or in shares of common stock upon a conversion.

 

b)          Default
Interest Rate. Upon an Event of Default hereunder, interest shall accrue daily on the outstanding principal amount of this
Note at a rate per annum equal to 18%.

 

Section 3.      Conversion
of Note; Prepayment, Exchange Right.  This Note shall be convertible into shares of Common Stock, on the terms
and conditions set forth in this Section 3.

 

(a)           Conversion
Right.  Subject to the provisions of Section 3(c), at any time or times on or after the date set out above
as the Original Issue Date (the “Original Issue Date”), the Holder shall be entitled to convert any portion
of the outstanding and unpaid Conversion Amount (as defined below) into fully paid and nonassessable shares of Common Stock in
accordance with Section 3(b), at the Conversion Price (as defined below) subject to the Conversion Minimum (as defined below).  The
number of shares of Common Stock issuable upon conversion of any Conversion Amount pursuant to this Section 3(a) shall be
equal to the quotient of dividing the Conversion Amount by the Conversion Price (“Conversion Shares”).  The
Company shall not issue any fraction of a share of Common Stock upon any conversion.  If the issuance would result in
the issuance of a fraction of a share of Common Stock, the Company shall round such fraction of a share of Common Stock up to the
nearest whole share.  The Company shall pay any and all transfer agent fees, legal fees, costs and any other fees or
costs that may be incurred or charged in connection with the issuance of shares of Common Stock to the Holder arising out of or
relating to the conversion of this Note.

 

    	 	3	 

     

    

 

(i)           “Conversion
Amount” means the portion of the principal and Interest to be converted, plus any penalties, redeemed or otherwise
with respect to which this determination is being made.

 

(ii)           
“Conversion Price” shall equal the lesser of (i) $0.90 and (ii) 75% of the price of the common stock
sold (or common stock equivalents if a convertible security issued) at the next financing completed by the Company with gross proceeds
of no less than $1 million, subject to adjustment as provided in this Note.

 

(iii)           “Conversion
Minimum” shall, unless otherwise approved in writing by the Company, constitute any individual conversion of at least
an amount equal to $10,000 of the principal.

 

(iv)           “VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on the Primary Market; (b) if the Common Stock is not then quoted
for trading on the Primary Market and if prices for the Common Stock are then reported in the “Pink Sheets” published
by Pink Sheets, LLC (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid
price per share of the Common Stock so reported; or (c) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company.

 

(b)           Mechanics
of Conversion.

 

(i)           Optional
Conversion. To convert any Conversion Amount into shares of Common Stock on any date (a “Conversion Date”),
the Holder shall transmit by email, facsimile (or otherwise deliver), for receipt on or prior to 11:59 p.m., New York, NY Time,
on such date, a copy of an executed notice of conversion in the form attached hereto as Exhibit A (the “Conversion
Notice”) to the Company.  On or before the third (3rd) Business Day following the date of receipt of a
Conversion Notice, the Company shall (A) if legends are not required to be placed on certificates of Common Stock pursuant to the
then existing provisions of Rule 144 of the Securities Act of 1933 (“Rule 144”) and provided that the
Company’s transfer agent is participating in the Depository Trust Company's (“DTC”) Fast Automated
Securities Transfer Program, credit such aggregate number of shares of Common Stock to which the Holder shall be entitled to the
Holder’s or its designee’s balance account with DTC, or (B) if the Company’s transfer agent is not participating
in the DTC Fast Automated Securities Transfer Program, issue and deliver to the address as specified in the Conversion Notice,
a certificate, registered in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder
shall be entitled which certificates shall not bear any restrictive legends unless required pursuant the Rule 144.  If
this Note is physically surrendered for conversion and the outstanding principal is greater than the principal portion of the Conversion
Amount being converted, then the Company shall, upon request of the Holder, as soon as practicable and in no event later than three
(3) Business Days after receipt of this Note and at its own expense, issue and deliver to the holder a new Note representing the
outstanding principal not converted.  The individual, corporation, partnership, limited liability company, limited liability
partnership, trust, association, organization or other entity (each a “Person”) entitled to receive the
shares of Common Stock issuable upon a conversion of this Note shall be treated for all purposes as the record holder or holders
of such shares of Common Stock upon the transmission of a Conversion Notice.  For the purposes hereof, the term “Business
Day” means any day except any Saturday, any Sunday, any day which shall be a federal legal holiday in the United
States or any day on which banking institutions in the State of California are authorized or required by law or other governmental
action to close.

 

    	 	4	 

     

    

 

(ii)           Company’s
Failure to Timely Convert. If within three (3) Business Days after the Company’s receipt of the facsimile or email copy
of a Conversion Notice, the Company shall fail to issue and deliver to Holder the number of shares of Common Stock to which the
Holder is entitled upon such Holder's conversion of any Conversion Amount (a “Conversion Failure”), then
in addition to any remedies available under 3(d)(iv) below, the principal shall increase by $3,000 per day until the Company issues
and delivers a certificate to the Holder for the number of shares of Common Stock to which the Holder is entitled upon such Holder’s
conversion of any Conversion Amount.  If the Company fails to deliver shares in accordance with the timeframe stated
in this Section, resulting in a Conversion Failure, the Holder, at any time prior to selling all of those shares, may rescind any
portion, in whole or in part, of that particular conversion attributable to the unsold shares and have the rescinded Conversion
Amount returned to the principal with the rescinded Conversion Shares returned to the Company.

 

(iii)           DTC
Eligibility.  If the Company loses its status as “DTC Eligible” for any reason, the Conversion Price
shall thereafter be redefined to mean $0.25, subject to further adjustment as provided in this Note.

 

(iv)           Book-Entry.  Notwithstanding
anything to the contrary set forth herein, upon conversion of any portion of this Note in accordance with the terms hereof, the
Holder shall not be required to physically surrender this Note to the Company unless (A) the full Conversion Amount represented
by this Note is being converted or (B) the Holder has provided the Company with prior written notice (which notice may be included
in a Conversion Notice) requesting reissuance of this Note upon physical surrender of this Note.  The Holder and the
Company shall maintain records showing the principal and Interest converted and the dates of such conversions or shall use such
other method, reasonably satisfactory to the Holder and the Company, so as not to require physical surrender of this Note upon
conversion.

 

    	 	5	 

     

    

 

(c)           Limitations
on Conversions.  The Company shall not effect any conversions of this Note and the Holder shall not have the right
to convert any portion of this Note or receive shares of Common Stock as payment of interest hereunder to the extent that after
giving effect to such conversion or receipt of such Interest payment, the Holder, together with any affiliate thereof, would beneficially
own (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and the rules promulgated thereunder) in excess of 4.99% of the number of shares of Common Stock outstanding
immediately after giving effect to such conversion or receipt of shares as payment of Interest.  Since the Holder will
not be obligated to report to the Company the number of shares of Common Stock it may hold at the time of a conversion hereunder,
unless the conversion at issue would result in the issuance of shares of Common Stock in excess of 4.99% of the then outstanding
shares of Common Stock without regard to any other shares which may be beneficially owned by the Holder or an affiliate thereof,
the Holder shall have the authority and obligation to determine whether the restriction contained in this Section will limit any
particular conversion hereunder and to the extent that the Holder determines that the limitation contained in this Section applies,
the determination of which portion of the principal amount of this Note is convertible shall be the responsibility and obligation
of the Holder.  If the Holder has delivered a Conversion Notice for a principal amount of this Note that, without regard
to any other shares that the Holder or its affiliates may beneficially own, would result in the issuance in excess of the permitted
amount hereunder, the Company shall notify the Holder of this fact and shall honor the conversion for the maximum principal amount
permitted to be converted on such Conversion Date in accordance with Section 3(a) and, any principal amount tendered for
conversion in excess of the permitted amount hereunder shall remain outstanding under this Note.  The provisions of this
Section may be waived by a Holder (but only as to itself and not to any other Holder) upon not less than sixty-five (65) days’
prior notice to the Company.  Other Holders shall be unaffected by any such waiver.

 

(d)           Other
Provisions.

 

(i)           Share
Reservation.      The Company shall at all times reserve and keep available out of its authorized
Common Stock a number of shares of Common Stock equal to 200% of the full number of shares of Common Stock issuable upon conversion
of all outstanding amounts under this Note.

 

(ii)           Prepayment.  At
any time the Company shall have the option, upon ten (10) Business Days’ written notice to Holder, to pre-pay the entire
remaining outstanding principal amount of this Note in cash, provided that (A) the Company shall pay the Holder one hundred twenty
percent (120%) of the principal plus Interest outstanding in repayment hereof, (B) such amount must be paid in cash on the next
Business Day following such ten (10) Business Day notice period, and (C) the Holder may still convert this Note pursuant to the
terms hereof at all times until such prepayment amount has been received in full.  In the event that the Company completes
a financing or a series of financings, with the same or different investors, that in the aggregate result in gross proceeds to
the Company of at least $3 million, then the Company is required to pre-pay and redeem the entire remaining outstanding principal
amount plus Interest of this Note in cash, provided that (A) the Company shall pay the Holder one hundred twenty percent (120%)
of the principal plus Interest outstanding in repayment hereof and (B) such amount must be paid in cash on the next Business Day
after receipt of the gross proceeds. Except as set forth in this Section 3, the Company may not prepay this Note in whole or in
part.

 

    	 	6	 

     

    

 

(iii)           All
calculations under this Section 3 shall be rounded up to the nearest $0.00001 or whole share.

 

(iv)           Nothing
herein shall limit a Holder’s right to pursue actual damages (such damages shall include but not be limited to the loss of
potential trading gains) or declare an Event of Default herein for the Company’s failure to deliver certificates representing
shares of Common Stock upon conversion within the period specified herein and such Holder shall have the right to pursue all remedies
available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief, in
each case without the need to post a bond or provide other security.  The exercise of any such rights shall not prohibit
the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.

 

Section 4.      Adjustments
to Conversion Price; Fundamental Transactions.  The Conversion Price and the number and kind of securities issuable
upon conversion of this Note shall be subject to adjustment from time to time as set forth in this Section 4.

 

(a)           Stock
Dividends and Splits.  If at any time while this Note is outstanding the Company (i) declares or pays a stock
dividend on its Common Stock or otherwise makes a distribution on any class of capital stock (or securities convertible into or
exercisable or exchangeable for capital stock) that is payable in shares of Common Stock, (ii) subdivides outstanding shares of
Common Stock into a larger number of shares, (iii) combines (including, without limitation, by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares
of capital stock of the Company (including, without limitation, in connection with any merger or consolidation), then in each such
case the Conversion Price then in effect shall be adjusted by multiplying such Conversion Price by a fraction of which (A) the
numerator shall be the number of shares of Common Stock outstanding immediately before such event, and (B) the denominator shall
be the number of shares of Common Stock outstanding immediately after such event.  Any adjustment made pursuant to clause
(i) of this paragraph shall become effective immediately after the record date for such dividend or distribution, and any adjustment
made pursuant to clauses (ii), (iii) or (iv) of this paragraph shall become effective immediately after the effective date of such
subdivision, combination or reclassification.

 

    	 	7	 

     

    

 

(b)           Pro
Rata Distributions.  Subject to Section 4(c) below, if at any time while this Note is outstanding the
Company declares or pays any dividend or otherwise distributes any of its assets (including, without limitation, cash, properties,
evidences of indebtedness, securities (including any options or other convertible securities but excluding a distribution of Common
Stock covered by Section 4(a) above or Purchase Rights covered by Section 4(c) below) or options or rights to acquire
any such assets) (in each case, “Distributed Property”) to all holders of Common Stock pro
rata (and not to all Holders in their capacity as holders of Notes), whether by way of dividend, return of capital, spin-off,
reclassification, corporate rearrangement, scheme of arrangement or other similar transaction, then in each such case the Conversion
Price in effect immediately prior to the close of business on the record date for such dividend or distribution shall be reduced,
effective as of the close of business on such record date, to a price determined by multiplying such Conversion Price by a fraction
of which (i) the denominator shall be the closing price of Common Stock on the Primary Market on such record date (the “Market
Price”), and (ii) the numerator shall be such Market Price minus the value of the Distributed Property on such date
applicable to one outstanding share of Common Stock, as determined by the Company’s independent certified public accounting
firm that regularly examines the financial statements of the Company.

 

(c)           Rights
Offerings Below Market.  Notwithstanding Section 4(b) above, if at any time while this Note is outstanding
the Company grants, issues or sells pro rata to all holders of its outstanding shares of Common Stock, any options, convertible
securities or other rights (the “Purchase Rights”) entitling them to directly or indirectly
subscribe for or purchase shares of Common Stock at an effective price per share less than the Market Price on the record date
of such grant, issuance or sale, then in each such case the Conversion Price in effect immediately prior to the close of business
on such record date shall be reduced, effective as of the close of business on such record date, to a price determined by multiplying
such Conversion Price by a fraction of which (i) the numerator shall be the number of shares of Common Stock outstanding as of
the close of business on such record date plus the number of shares of Common Stock which the aggregate offering price of the total
number of shares so offered for subscription or purchase (including and assuming receipt by the Company in full of all consideration
payable upon both issuance and exercise of such Purchase Rights) would purchase at such Market Price, and (ii) the denominator
shall be the number of shares of Common Stock outstanding as of the close of business on such record date plus the total number
of additional shares of Common Stock so offered for subscription or purchase; provided, that in lieu of receiving such adjustment
to the Conversion Price, the Holder shall have the option, upon written notice to the Company within thirty (30) days following
its receipt of the notice of such adjustment, to elect to acquire, upon any conversion of this Note and in accordance with the
terms applicable to the issuance of such Purchase Rights, the aggregate Purchase Rights which the Holder would have acquired if
the Holder had converted such portion of this Note being converted (without regard to any limitations on ownership or conversion
and regardless of whether this Note was then convertible) immediately prior to such record date.  To the extent that
shares of Common Stock have not been delivered pursuant to such Purchase Rights specified in this Section upon the expiration or
termination of such Purchase Rights, the Conversion Price shall be readjusted to the Conversion Price which would then be in effect
had the adjustment made upon the issuance of such Purchase Rights been made on the basis of delivery of only the number of shares
of Common Stock actually delivered. In determining whether any Purchase Rights entitle the holder thereof to subscribe for or purchase
shares of Common Stock at less than such Market Price, and in determining the aggregate offering price of such shares of Common
Stock, there shall be taken into account any consideration received for such Purchase Rights, the value of such consideration (if
other than cash) to be determined in good faith by the Company’s Board of Directors.

 

    	 	8	 

     

    

 

(d)           Fundamental
Transactions.  If at any time while this Note is outstanding, (i) the Company effects any merger or consolidation
of the Company with or into another Person, (ii) the Company effects any sale of all or substantially all of its assets in one
or a series of related transactions, (iii) any tender offer or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to tender or exchange their shares for other securities, cash or property,
or (iv) the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property (each, a “Fundamental Transaction”),
then the Holder shall have the right thereafter to receive, upon any conversion of this Note, for each Conversion Share that would
have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction, the same amount and
kind of securities, cash and property as the Holder would have been entitled to receive upon the occurrence of such Fundamental
Transaction if the Holder had been the record holder of one Conversion Share immediately prior to such Fundamental Transaction
(without regard to any limitations or restrictions on conversion or acquisition of Conversion Shares and whether or not this Note
was then convertible) (the “Alternate Consideration”), and the Conversion Price shall be appropriately
and equitably adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such Fundamental Transaction relative to the then Conversion Price.  The Company shall
apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it
receives upon any conversion of this Note following such Fundamental Transaction.  In case of any such Fundamental Transaction,
any successor to the Company, acquirer or surviving entity (if other than the Company) shall expressly assume the due and punctual
observance and performance of each and every covenant, obligation, liability and condition under this Note to be performed and
observed by the Company, subject to such modifications as may be reasonably deemed appropriate (as determined in good faith by
resolution of the Board of Directors of the Company) in order to provide for adjustments of the number and kind of Conversion Shares
for which this Note is convertible which shall be as nearly equivalent as practicable to the adjustments provided for in this Section.  Such
assumption shall be pursuant to a written agreement in form and substance reasonably satisfactory to the Holder.  At
the Holder’s request, any successor to the Company, acquirer or surviving entity in such Fundamental Transaction shall issue
to the Holder a new Note from such entity substantially similar in form and substance to this Note and consistent with the foregoing
provisions, which new Note shall be reasonably satisfactory to the Holder and include, without limitation, (A) the outstanding
principal and Interest owed to the Holder under this Note, (B) an interest rate equal to the Interest Rate, (C) similar ranking
to this Note, and (D) the Holder’s right to convert the new Note into Alternate Consideration.  The terms of any
agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor, acquirer or
surviving entity to comply with the provisions of this Section and ensuring that this Note (or any such replacement security) will
be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction.  Notwithstanding anything
to the contrary contained herein, if a Fundamental Transaction (X) is an all cash transaction, (Y) constitutes or results in a
“Rule 13e-3 transaction” as defined in Rule 13e-3 under the Exchange Act (going private transaction), or (Z) otherwise
results in the successor, surviving or acquiring entity not being traded on a national securities exchange, the Nasdaq Global Select
Market, the Nasdaq Global Market or the Nasdaq Capital Market, then upon the written request of the Holder, delivered before the
sixtieth (60th) day after such Fundamental Transaction, the Company (or any such successor, acquirer or surviving entity) shall
redeem this Note from the Holder for a redemption price, payable in cash within five (5) Business Days after such request (or,
if later, on the effective date of such Fundamental Transaction), equal to the value of this Note as determined using the Black-Scholes
Option Pricing Model via Bloomberg.  The provisions of this Section shall similarly apply to successive Fundamental Transactions
and shall be applied without regard to any limitations of this Note.

 

    	 	9	 

     

    

 

Section
5.            Intentionally Deleted.

 

Section 6.            Events
of Default. 

 

a)         “Event
of Default” means, wherever used herein, any of the following events (whatever the reason for such event and whether
such event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any
court, or any order, rule or regulation of any administrative or governmental body):

 

i.          any
default in the payment of (A) the principal amount under this Note, or (B) interest, liquidated damages and other amounts owing
under this Note as and when the same shall become due and payable (whether on the Maturity Date or by acceleration or otherwise)
which default is not cured within 3 business days;

 

ii.         the
Company shall fail to observe or perform any other covenant or agreement contained in this Note which failure is not cured, if
possible to cure, within 5 days after notice of such failure is delivered by the Holder or after the Company has become or should
have become aware of such failure, whichever is earlier;

 

iii.        a
default or event of default (subject to any grace or cure period provided in the applicable agreement, document or instrument)
shall occur under (A) the Purchase Agreement or (B) any other material agreement, lease, document or instrument to which the Company
or any Subsidiary is obligated (and not otherwise covered below);

 

    	 	10	 

     

    

 

iv.        the
Company or any Subsidiary shall be subject to a Bankruptcy Event;

 

v.         the
Company or any Subsidiary shall default on any of its obligations under any mortgage, credit agreement or other facility, indenture
agreement, factoring agreement or other instrument under which there may be issued, or by which there may be secured or evidenced,
any indebtedness for borrowed money or money due under any long term leasing or factoring arrangement that (a) involves an obligation
greater than $10,000, whether such indebtedness now exists or shall hereafter be created, and (b) results in such indebtedness
becoming or being declared due and payable prior to the date on which it would otherwise become due and payable;

 

vi.        the
Company shall be a party to any Change of Control Transaction or shall agree to sell or dispose of all or in excess of 33% of its
assets in one transaction or a series of related transactions (whether or not such sale would constitute a Change of Control Transaction);

 

vii.       any
monetary judgment, writ or similar final process shall be entered or filed against the Company, any Subsidiary or any of their
respective properties or other assets for more than $10,000, and such judgment, writ or similar final process shall remain unvacated,
unbonded or unstayed for a period of 45 calendar days; or

 

viii.      The
common stock of the Company (“Common Stock”) is suspended or delisted for trading on the Over the Counter
Bulletin Board market (the “Primary Market”) and the OTCQB;

 

ix.        A
Conversion Failure as defined in Section 3(b)(ii) hereof;

 

x.         The
Company loses its status as “DTC Eligible”; or

 

xi.        The
Company shall become late or delinquent in its filing requirements as a fully-reporting issuer registered with the Securities &
Exchange Commission.

 

b)         Remedies
Upon Event of Default. If any Event of Default occurs, the outstanding principal amount of this Note, plus accrued but unpaid
interest, liquidated damages and other amounts owing in respect thereof through the date of acceleration, shall become, at the
Holder’s election, immediately due and payable in cash at the Mandatory Default Amount. After the occurrence and during the
continuance of any Event of Default, the interest rate on this Note shall accrue at an interest rate equal to the lesser of 18%
per annum or the maximum rate permitted under applicable law. In connection with such acceleration described herein, the Holder
need not provide, and the Company hereby waives, any presentment, demand, protest or other notice of any kind, and the Holder may
immediately and without expiration of any grace period enforce any and all of its rights and remedies hereunder and all other remedies
available to it under applicable law.

 

    	 	11	 

     

    

 

Section 7.         Miscellaneous.

 

a)       Notices.
Any and all notices or other communications or deliveries to be provided by the Holder hereunder, shall be in writing and delivered
personally, by facsimile, by email or sent by a nationally recognized overnight courier service, addressed to the Company, at the
address set forth above, or such other facsimile number, email or address as the Company may specify for such purpose by notice
to the Holder delivered in accordance with this Section. Any and all notices or other communications or deliveries to be provided
by the Company hereunder shall be in writing and delivered personally, by facsimile, by email or sent by a nationally recognized
overnight courier service addressed to each Holder at the facsimile number or address of the Holder appearing on the books of the
Company, or if no such facsimile number, email or address appears, at the principal place of business of the Holder. Any notice
or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission,
if such notice or communication is delivered via facsimile or email at the facsimile number or email address specified to such
party prior to 8:30 p.m. (New York City time), (ii) the date immediately following the date of transmission, if such notice or
communication is delivered via facsimile or email at the facsimile number or email address specified to such party between 8:30
p.m. (New York City time) and 11:59 p.m. (New York City time) on any date, (iii) the second Business Day following the date of
mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications shall be as set forth in the Purchase Agreement.

 

b)       Absolute
Obligation. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of the Company,
which is absolute and unconditional, to pay the principal of, liquidated damages and accrued interest, as applicable, on this Note
at the time, place, and rate, and in the coin or currency, herein prescribed. This Note is a direct debt obligation of the Company.         

 

c)       Lost
or Mutilated Note. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in exchange
and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed
Note, a new Note for the principal amount of this Note so mutilated, lost, stolen or destroyed, but only upon receipt of evidence
of such loss, theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to the Company, as well as
an affidavit and indemnification agreement in form and substance reasonably acceptable to the Company.

 

    	 	12	 

     

    

 

d)       Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Note shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflict
of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions
contemplated by this Note or the Purchase Agreement (whether brought against a party hereto or its respective affiliates, directors,
officers, shareholders, employees or agents) shall be commenced in the state and federal courts sitting in the City of New York,
Borough of Manhattan (the “New York Courts”). Each party hereto hereby irrevocably submits to the exclusive
jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of this Note or the Purchase Agreement), and
hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each
party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the
address in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other
manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable
law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Note or the transactions contemplated
hereby. If either party shall commence an action or proceeding to enforce any provisions of this Note, then the prevailing party
in such action or proceeding shall be reimbursed by the other party for its attorney’s fees and other costs and expenses
reasonably incurred in the investigation, preparation and prosecution of such action or proceeding.

 

e)       Waiver;
Amendments. Any waiver by the Company or the Holder of a breach of any provision of this Note shall not operate as or be construed
to be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The failure of the Company
or the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not be considered a waiver
or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Note. Any
waiver by the Company or the Holder must be in writing. This Note shall not be directly or indirectly effectively modified or amended
without the prior written consent of the Holder.

 

f)         Successors
and Assigns. This Note may be assigned by the Holder with the prior written consent of the Company. This Note may not be assigned
by the Company, except to a successor in the event of a Fundamental Transaction. This Note shall be binding on and inure to the
benefit of the parties thereto and their respective successors and assigns.

 

g)       Severability.
If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain in effect, and if any
provision is inapplicable to any person or entity or circumstance, it shall nevertheless remain applicable to all other persons,
entities and circumstances.

 

    	 	13	 

     

    

 

h)       Next
Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment
shall be made on the next succeeding Business Day.

 

i)         Headings.
The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit
or affect any of the provisions hereof.

 

j)         Assumption. 
Any successor to the Company or any surviving entity in a Fundamental Transaction shall (i) assume, prior to such Fundamental Transaction,
all of the obligations of the Company under this Note and the Purchase Agreement pursuant to written agreements in form and substance
satisfactory to the Holder (such approval not to be unreasonably withheld or delayed) and (ii) issue to the Holder a new Note of
such successor entity evidenced by a written instrument substantially similar in form and substance to this Note, including, without
limitation, having a principal amount and interest rate equal to the principal amount and the interest rate of this Note and having
similar ranking to this Note, which shall be satisfactory to the Holder (any such approval not to be unreasonably withheld or delayed).
 The provisions of this Section shall apply similarly and equally to successive Fundamental Transactions and shall be applied
without regard to any limitations of this Note.

 

k)       No
Usury. To the fullest extent permitted by law, the Company agrees not to insist upon or plead or in any manner whatsoever claim,
and shall resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, in force
at the time of execution of this Note or hereafter, in connection with any action that may be brought by the Holder in order to
enforce any right or remedy under this Note or other Transaction Documents. Notwithstanding any provision to the contrary contained
herein, it is expressly agreed and provided that the total liability of the Company under this Note for payments in the nature
of interest shall not exceed the maximum lawful interest rate authorized under applicable law. If the effective interest rate otherwise
applicable under this Note exceeds such maximum lawful interest rate, then such applicable interest rate shall be reduced so as
not to exceed such maximum lawful interest rate.

 

*********************

 

    	 	14	 

     

    

 

IN WITNESS WHEREOF,
the Company has caused this Note to be duly executed by a duly authorized officer as of the date first above indicated.

 

	 	NUGENE INTERNATIONAL, INC.
	 	 
	 	By: /s/ Ali Kharazmi
	 	Name:   Ali Kharazmi
	 	Title:   Chief Executive Officer

 

    	 	15	 

     

    

 

EXHIBIT A

 

NOTICE OF CONVERSION

 

The undersigned hereby elects to convert
principal under the 10% Convertible Note (the “Note”) due December 1, 2016 of NUGENE INTERNATIONAL, INC.,
a Nevada corporation (the “Company”), into shares of common stock (“Common Stock”)
of the Company according to the conditions hereof, as of the date written below.

 

	Conversion calculations:	Date to Effect Conversion:	 
	 	 	 	 
	 	Principal to be Converted:	 
	 	 	 	 
	 	Interest Accrued on Account of Conversion at Issue:	 
	 	 	 	 
	 	Number of shares of Common Stock to be issued (not less than
	 	$10,000 of the principal and any accrued but unpaid interest
	 	thereon:	 	 
	 	 	 	 
	 	 	Signature:	 
	 	 	 	 
	 	 	Name:	 
	 	 	 	 
	 	 	Address for Delivery of Common Stock Certificates:
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

    	 	16Exhibit 10.16

 

THIS WARRANT AND THE COMMON SHARES
ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES
LAWS. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED
IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS
OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO NUGENE INTERNATIONAL, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

 

Right to Purchase up to 61,111 Shares of
Common Stock of

NUGENE INTERNATIONAL, INC.

(subject to adjustment as provided herein)

 

COMMON STOCK PURCHASE WARRANT

 

	No. RBW-1	Issue Date:  December 9, 2015

 

NUGENE
INTERNATIONAL, INC., a corporation organized under the laws of Nevada (the “Company”), hereby certifies that,
for value received, RBW, INC., or assigns (the “Holder”), is entitled, subject to the terms set forth below,
to purchase from the Company (as defined herein) from and after the Issue Date of this Warrant and at any time, up to 61,111 fully
paid and nonassessable shares of Common Stock (as hereinafter defined), par value of $0.0001 per share, at the applicable Exercise
Price per share (as defined below). The number and character of such shares of Common Stock and the applicable Exercise Price per
share are subject to adjustment as provided herein.

 

This Warrant has been
issued pursuant to the terms of that certain Securities Purchase Agreement, dated as of December 9, 2015 (the “Purchase
Agreement”), by and among the Company and Purchaser party thereto, including the Holder. Capitalized terms not defined
herein shall have the meanings given to them in the Purchase Agreement. As used herein the following terms, unless the context
otherwise requires, have the following respective meanings:

 

(a)          “Aggregate
Exercise Price” means an amount equal to the product of (i) the number of shares of Common Stock in respect of which
this Warrant is being exercised pursuant to Section 2 hereof, multiplied by (ii) the then-current Exercise Price.

 

(b)          “Business
Day” means any day, except a Saturday, Sunday or legal holiday, on which banking institutions in the city of New York,
New York are authorized or obligated by law or executive order to close.

 

(c)          The
term “Company” shall mean NUGENE INTERNATIONAL, INC. and any person or entity which shall succeed, or assume
the obligations of, NUGENE INTERNATIONAL, INC. hereunder.

 

(d)          The
term “Common Stock” shall mean (i) the Company’s common shares, $0.0001 par value per share; and (ii)
any other securities into which or for which any of the securities described in the preceding clause (i) may be converted or exchanged
pursuant to a plan of recapitalization, reorganization, merger, sale of assets or otherwise.

 

    	 	Page 1 of 11	 

     

    

 

(e)          The
term “Exercise Price” shall mean $1.50 per share, subject to adjustments as provided herein, however in no event
shall the Exercise Price be adjusted to a price below $0.50 (the “Floor Price”)

 

(f)          The
term “Other Securities” shall mean any stock (other than Common Stock) and other securities of the Company or
any other person (corporate or otherwise) which the holder of the Warrant at any time shall be entitled to receive, or shall have
received, on the exercise of the Warrant, in lieu of or in addition to Common Stock, or which at any time shall be issuable or
shall have been issued in exchange for or in replacement of Common Stock or Other Securities pursuant to Section 4 or otherwise.

 

(g)          “Trading
Day” means a day on which the principal Trading Market is open for trading.

 

(h)          “Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New
York Stock Exchange, the OTC Bulletin Board or the OTC Markets (or any successors to any of the foregoing).

 

1.           Term
of Warrant. Subject to the terms and conditions hereof, at any time or from time to time after the date hereof and prior to
5:00 p.m., New York time, on the fifth (5th) anniversary of the date hereof or, if such day is not a Business Day, on the next
preceding Business Day (the “Exercise Period”) the Holder of this Warrant may exercise this Warrant in whole
or in part, of the Common Stock purchasable upon exercise hereof (subject to adjustment as provided herein).

 

2.           Exercise
of Warrant.

 

2.1         Number
of Shares Issuable upon Exercise. From and after the date hereof, the Holder shall be entitled to receive, upon exercise of
this Warrant in whole or in part, upon surrender of this Warrant to the Company at its principal executive office (or an indemnification
undertaking with respect to this Warrant in the case of loss, theft, or destruction), or by delivery of an original or fax copy
of an exercise notice in the form attached hereto as Exhibit A (the “Exercise Notice”), duly completed,
and payment to the Company of the Aggregate Exercise Price, the Holder shall be entitled to receive, shares of Common Stock of
the Company, subject to adjustment pursuant to Section 5.

 

2.2         Fair
Market Value. For purposes hereof, the “Fair Market Value” of a share of Common Stock as of a particular
date (the “Determination Date”) shall mean the greater of:

 

(a)         The
closing sale price of a share of common stock on the Issue Date.

 

(b)         If
the Company’s Common Stock is traded on the NYSE MKT or another national exchange, then the closing or last sale price, respectively,
reported for the last Business Day immediately preceding the Determination Date.

 

    	 	Page 2 of 11	 

     

    

 

(c)          If
the Company’s Common Stock is not traded on the NYSE MKT or another national exchange but is traded on the Over The Counter
Bulletin Board operated by FINRA or the OTC Markets, then the mean of the average of the closing bid and asked prices reported
for the last Business Day immediately preceding the Determination Date.

 

(d)          Except
as provided in clause (d) below, if the Company’s Common Stock is not publicly traded, then as the Holder and the Board of
Directors of the Company jointly agree or in the absence of agreement by arbitration in accordance with the rules then in effect
of the American Arbitration Association, before a single arbitrator to be chosen from a panel of persons qualified by education
and training to pass on the matter to be decided.

 

(e)          If
the Determination Date is the date of a liquidation, dissolution or winding up, or any event deemed to be a liquidation, dissolution
or winding up pursuant to the Company’s charter, then all amounts to be payable per share to holders of the Common Stock
pursuant to the charter in the event of such liquidation, dissolution or winding up, plus all other amounts to be payable per share
in respect of the Common Stock in liquidation under the charter, assuming for the purposes of this clause (d) that all of the shares
of Common Stock then issuable upon exercise of the Warrant are outstanding at the Determination Date.

 

2.3         Company
Acknowledgment. The Company will, at the time of the exercise of this Warrant, upon the request of the Holder acknowledge in
writing its continuing obligation to afford to such Holder any rights to which such Holder shall continue to be entitled after
such exercise in accordance with the provisions of this Warrant. If the Holder shall fail to make any such request, such failure
shall not affect the continuing obligation of the Company to afford to such Holder any such rights.

 

2.4         Trustee
for Warrant Holders. In the event that a bank or trust company shall have been appointed as trustee for the holders of this
Warrant pursuant to Subsection 3.2, such bank or trust company shall have all the powers and duties of a warrant agent (as hereinafter
described) and shall accept, in its own name for the account of the Company or such successor person as may be entitled thereto,
all amounts otherwise payable to the Company or such successor, as the case may be, on exercise of this Warrant pursuant to this
Section 1.

 

3.           Procedure
for Exercise.

 

3.1         Delivery
of Stock Certificates, Etc., on Exercise. The Company agrees that the shares of Common Stock purchased upon exercise of this
Warrant shall be deemed to be issued to the Holder as the record owner of such shares as of the close of business on the date on
which this Warrant shall have been surrendered and payment made for such shares in accordance herewith. Not later than three (3)
Trading Days after such date (the “Share Delivery Date”), the Company shall deliver, or cause to be delivered,
to the holder (A) a certificate or certificates representing the shares of Common Stock purchased upon exercise of this Warrant
which, on or after the earlier of (i) the six month anniversary of the Issue Date, provided the Holder is not an Affiliate, shall
be free of restrictive legends and trading restrictions (other than those which may then be required by the Purchase Agreement)
representing the number of shares of Common Stock purchased upon exercise of this Warrant. On or after the six month anniversary
of the Issue Date, provided the Holder is not an Affiliate, the Company shall use its best efforts to deliver any certificate or
certificates required to be delivered by the Company under this Section 3.1 electronically through the Depository Trust Company
or another established clearing corporation performing similar functions.

 

    	 	Page 3 of 11	 

     

    

  

3.2         Failure
to Deliver Certificates. If, in the case of any Exercise Notice, such certificate or certificates are not delivered to or as
directed by the applicable holder by the Share Delivery Date, the holder shall be entitled to elect by written notice to the Company
at any time on or before its receipt of such certificate or certificates, to rescind such Exercise Notice, in which event the Company
shall promptly return to the holder any original Warrant delivered to the Company and the holder shall promptly return to the Company
the Common Stock certificates issued to such holder pursuant to the rescinded Exercise Notice.

 

3.3         Obligation
Absolute; Partial Liquidated Damages. The Company’s obligations to issue and deliver the shares of Common Stock purchased
upon exercise of this Warrant upon exercise of this Warrant in accordance with the terms hereof are absolute and unconditional,
irrespective of any action or inaction by the holder to enforce the same, any waiver or consent with respect to any provision hereof,
the recovery of any judgment against any person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation
or termination, or any breach or alleged breach by the holder or any other person of any obligation to the Company or any violation
or alleged violation of law by the holder or any other person, and irrespective of any other circumstance which might otherwise
limit such obligation of the Company to the Holder in connection with the issuance of such shares of Common Stock purchased upon
exercise of this Warrant; provided, however, that such delivery shall not operate as a waiver by the Company of any
such action the Company may have against the holder. In the event the holder of this Warrant shall elect to exercise any or all
portion hereof, the Company may not refuse exercise based on any claim that the holder or anyone associated or affiliated with
the holder has been engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice
to holder, restraining and or enjoining exercise of all or part of this Warrant shall have been sought and obtained, and the Company
posts a surety bond for the benefit of the holder in the amount of 150% of the value of the shares of Common Stock to be purchased
upon exercise of this Warrant, which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation
of the underlying dispute and the proceeds of which shall be payable to the holder to the extent it obtains judgment. In the absence
of such injunction, the Company shall issue the shares of Common Stock purchased upon exercise of this Warrant, upon a properly
noticed exercise. If the Company fails for any reason to deliver to the holder such certificate or certificates pursuant to Section
3.1 by the Share Delivery Date, the Company shall pay to the holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Fair Market Value of the shares of Common Stock to be purchased upon exercise of this Warrant, $10 per Trading Day (increasing
to $20 per Trading Day on the fifth (5th) Trading Day after such liquidated damages begin to accrue) for each Trading
Day after such Share Delivery Date until such certificates are delivered or holder rescinds such exercise. Nothing herein shall
limit a holder’s right to pursue actual damages for the Company’s failure to deliver the shares of Common Stock purchased
upon exercise of this Warrant within the period specified herein and the holder shall have the right to pursue all remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.
The exercise of any such rights shall not prohibit the holder from seeking to enforce damages pursuant to any other Section hereof
or under applicable law.

 

    	 	Page 4 of 11	 

     

    

 

3.4         Compensation
for Buy-In on Failure to Timely Deliver Certificates Upon Exercise. In addition to any other rights available to the holder,
if the Company fails for any reason to deliver to the holder such certificate or certificates by the Share Delivery Date pursuant
to Section 3.1, and if after such Share Delivery Date the holder is required by its brokerage firm to purchase (in an open market
transaction or otherwise), or the holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the holder of the shares of Common Stock purchased upon exercise of this Warrant which the Holder was entitled to
receive upon the exercise relating to such Share Delivery Date (a “Buy-In”), then the Company shall (A) pay
in cash to the holder (in addition to any other remedies available to or elected by the holder) the amount, if any, by which (x)
the holder’s total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the
product of (1) the aggregate number of shares of Common Stock that the Holder was entitled to receive from the exercise at issue
multiplied by (2) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including
any brokerage commissions) and (B) at the option of the holder, either reissue (if surrendered) this Warrant representing that
number of shares of Common Stock which it represented prior to such exercise (in which case such exercise shall be deemed rescinded)
or deliver to the holder the number of shares of Common Stock that would have been issued if the Company had timely complied with
its delivery requirements under Section 3.1. For example, if the holder purchases Common Stock having a total purchase price of
$11,000 to cover a Buy-In with respect to an attempted exercise of this Warrant with respect to which the actual sale price of
the shares of Common Stock purchased upon exercise of this Warrant (including any brokerage commissions) giving rise to such purchase
obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the Company shall be required to pay
the holder $1,000. The holder shall provide the Company written notice indicating the amounts payable to the holder in respect
of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a holder’s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares
of Common Stock upon exercise of this Warrant as required pursuant to the terms hereof.

 

    	 	Page 5 of 11	 

     

    

 

3.5         Holder’s
Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a holder shall not have the right to exercise
any portion of this Warrant, to the extent that after giving effect to the exercise set forth on the applicable Exercise Notice,
the holder (together with the holder’s Affiliates, and any Persons acting as a group together with the holder or any of the
holder’s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For
purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the holder and its Affiliates shall
include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which are issuable upon (i) exercise of the remaining, exercised
portion of this Warrant beneficially owned by the holder or any of its Affiliates and (ii) exercise or conversion of the unexercised
or unconverted portion of any other securities of the Company subject to a limitation on conversion or exercise analogous to the
limitation contained herein (including, without limitation, any other Warrants or the Debentures) beneficially owned by the holder
or any of its Affiliates.  Except as set forth in the preceding sentence, for purposes of this Section 3.5, beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
To the extent that the limitation contained in this Section 3.5 applies, the determination of whether this Warrant is convertible
(in relation to other securities owned by the holder together with any Affiliates) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the holder, and the submission of an Exercise Notice shall be deemed to be the holder’s
determination of whether this Warrant may be exercised (in relation to other securities owned by the holder together with any Affiliates)
and which principal amount of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation. To ensure
compliance with this restriction, the holder will be deemed to represent to the Company each time it delivers an Exercise Notice
that such Exercise Notice has not violated the restrictions set forth in this paragraph and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above
shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 3.5, in determining the number of outstanding shares of Common Stock, the holder may rely on the number
of outstanding shares of Common Stock as stated in the most recent of the following: (i) the Company’s most recent periodic
or annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Company, or (iii)
a more recent written notice by the Company or the Company’s transfer agent setting forth the number of shares of Common
Stock outstanding.  Upon the written or oral request of a holder, the Company shall within two Trading Days confirm orally
and in writing to the holder the number of shares of Common Stock then outstanding.  In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was
reported. The “Beneficial Ownership Limitation” shall be 9.99% of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant held by the holder.
The holder, upon not less than 61 days’ prior notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 3.5. Any such increase or decrease will not be effective until the 61st day after such notice
is delivered to the Company. The Beneficial Ownership Limitation provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 3.5 to correct this paragraph (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or
supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall
apply to a successor holder of this Warrant.

 

3.6         Exercise.

 

(a)          Payment
may be made in cash by wire transfer of immediately available funds to an account designated in writing by the Company, or by certified
or official bank check payable to the order of the Company equal to the Aggregate Exercise Price for the number of Common Shares
specified in such Exercise Notice (as such exercise number shall be adjusted to reflect any adjustment in the total number of shares
of Common Stock issuable to the Holder per the terms of this Warrant) and the Holder shall thereupon be entitled to receive the
number of duly authorized, validly issued, fully-paid and non-assessable shares of Common Stock (or Other Securities) determined
as provided herein.

 

(b)          Notwithstanding
the provisions of subsection (a) above to the contrary, if at the time the Holder exercises this Warrant either (i) in cash by
wire transfer of immediately available funds to an account designated in writing by the Company or by certified or official bank
check payable to the order of the Company equal to the applicable Aggregate Exercise Price, (ii) by delivery of this Warrant, or
shares of Common Stock and/or Common Stock receivable upon exercise of this Warrant in accordance with the formula set forth in
subsection (c) below, or (iii) by a combination of any of the foregoing methods, for the number of Common Shares specified in such
Exercise Notice (as such exercise number shall be adjusted to reflect any adjustment in the total number of shares of Common Stock
issuable to the Holder per the terms of this Warrant) and the Holder shall thereupon be entitled to receive the number of duly
authorized, validly issued, fully-paid and non-assessable shares of Common Stock (or Other Securities) determined as provided herein.

 

    	 	Page 6 of 11	 

     

    

  

(c)          In
accordance with subsection (b) above, if the Fair Market Value of one share of Common Stock is greater than the Exercise Price
(at the date of calculation as set forth below), in lieu of exercising this Warrant for cash, the Holder may elect to receive shares
equal to the value (as determined below) of this Warrant (or the portion thereof being exercised) by surrender of this Warrant
at the principal office of the Company together with the properly endorsed Exercise Notice in which event the Company shall issue
to the Holder a number of shares of Common Stock computed using the following formula:

 

		X=	 Y(A-B) 

    A

 

		Where X =	the number of shares of Common Stock to be issued to
the Holder

 

		Y =	the number of shares of Common Stock purchasable under
this Warrant or, if only a portion of this Warrant is being exercised, the portion of this Warrant being exercised (at the date
of such calculation)

 

		A =	the Fair Market Value of one share of the Company’s
Common Stock

 

		B =	the Exercise Price per share (as adjusted to the date
of such calculation)

 

4.          Effect
of Reorganization, Etc.; Adjustment of Exercise Price.

 

4.1          Reorganization,
Consolidation, Merger, Etc. In case at any time or from time to time the Company shall (a) effect a reorganization, (b) consolidate
with or merge into any other person, or (c) transfer all or substantially all of its properties or assets to any other person under
any plan or arrangement contemplating the dissolution of the Company, then, in each such case, as a condition to the consummation
of such a transaction, proper and adequate provision shall be made by the Company whereby the Holder, on the exercise hereof as
provided in Section 1 at any time after the consummation of such reorganization, consolidation or merger or the effective date
of such dissolution, as the case may be, upon closing date of any such reorganization, consolidation, merger or sale or transfer
of assets, shall receive, in lieu of the Common Stock (or Other Securities) issuable on such exercise prior to such consummation
or such effective date, the stock and other securities and property (including cash) to which such Holder would have been entitled
upon such consummation or in connection with such dissolution, as the case may be, if such Holder had so exercised this Warrant,
immediately prior thereto, all subject to further adjustment thereafter as provided in Section 5.

 

4.2         Dissolution.
In the event of any dissolution of the Company following the transfer of all or substantially all of its properties or assets,
the Company, concurrently with any distributions made to holders of its Common Stock, shall at its expense deliver or cause to
be delivered to the Holder the stock and other securities and property (including cash, where applicable) receivable by the Holder
pursuant to Section 4.1, or, if the Holder shall so instruct the Company, to a bank or trust company specified by the Holder and
having its principal office in New York, NY as trustee for the Holder (the “Trustee”).

 

    	 	Page 7 of 11	 

     

    

 

4.3         Continuation
of Terms. Upon any reorganization, consolidation, merger or transfer (and any dissolution following any transfer) referred
to in this Section 4, this Warrant shall continue in full force and effect and the terms hereof shall be applicable to the shares
of stock and other securities and property receivable on the exercise of this Warrant after the consummation of such reorganization,
consolidation or merger or the effective date of dissolution following any such transfer, as the case may be, and shall be binding
upon the issuer of any such stock or other securities, including, in the case of any such transfer, the person acquiring all or
substantially all of the properties or assets of the Company, whether or not such person shall have expressly assumed the terms
of this Warrant as provided in Section 5. In the event this Warrant does not continue in full force and effect after the consummation
of the transactions described in this Section 4, then the Company’s securities and property (including cash, where applicable)
receivable by the Holder will be delivered to the Holder or the Trustee as contemplated by Section 4.2.

 

5.          Extraordinary
Events Regarding Common Stock. In the event that the Company shall (a) issue additional shares of the Common Stock as a dividend
or other distribution on outstanding Common Stock or any preferred stock issued by the Company, (b) subdivide its outstanding shares
of Common Stock, or (c) combine its outstanding shares of the Common Stock into a smaller number of shares of the Common Stock,
then, in each such event, the Exercise Price shall, simultaneously with the happening of such event, be adjusted by multiplying
the then Exercise Price by a fraction, the numerator of which shall be the number of shares of Common Stock outstanding immediately
prior to such event and the denominator of which shall be the number of shares of Common Stock outstanding immediately after such
event, and the product so obtained shall thereafter be the Exercise Price then in effect. The Exercise Price, as so adjusted, shall
be readjusted in the same manner upon the happening of any successive event or events described herein in this Section 5. The number
of shares of Common Stock that the Holder shall thereafter, on the exercise hereof as provided in Section 2, be entitled to receive
shall be adjusted to a number determined by multiplying the number of shares of Common Stock that would otherwise (but for the
provisions of this Section 5) be issuable on such exercise by a fraction of which (a) the numerator is the Exercise Price that
would otherwise (but for the provisions of this Section 4) be in effect, and (b) the denominator is the Exercise Price in effect
on the date of such exercise (taking into account the provisions of this Section 5). Notwithstanding the foregoing, in no event
shall the Exercise Price be less than the par value of the Common Stock.

 

6.          Intentionally
Deleted.

 

7.          Pro
Rata Distributions. If the Company, at any time prior to the Expiration Date, shall distribute to all holders of Common Stock
(and not to Holders of the Warrants) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants
to subscribe for or purchase any security), then in each such case the Exercise Price shall be adjusted by multiplying the Exercise
Price in effect immediately prior to the record date fixed for determination of stockholders entitled to receive such distribution
by a fraction of which the denominator shall be the Fair Market Value determined as of the record date mentioned above, and of
which the numerator shall be such Fair Market Value on such record date less the then per share Fair Market Value at such record
date of the portion of such assets or evidence of indebtedness so distributed applicable to one outstanding share of the Common
Stock as determined by the Board of Directors in good faith. In either case the adjustments shall be described in a statement provided
to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable to one
share of Common Stock. Such adjustment shall be made whenever any such distribution is made and shall become effective immediately
after the record date mentioned above.

 

    	 	Page 8 of 11	 

     

    

 

8.          Certificate
as to Adjustments. In each case of any adjustment or readjustment in the shares of Common Stock (or Other Securities) issuable
on the exercise of this Warrant, the Company at its expense will promptly cause its Chief Financial Officer or other appropriate
designee to compute such adjustment or readjustment in accordance with the terms of this Warrant and prepare a certificate setting
forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including
a statement of (a) the consideration received or receivable by the Company for any additional shares of Common Stock (or Other
Securities) issued or sold or deemed to have been issued or sold, (b) the number of shares of Common Stock (or Other Securities)
outstanding or deemed to be outstanding, and (c) the Exercise Price and the number of shares of Common Stock to be received upon
exercise of this Warrant, in effect immediately prior to such adjustment or readjustment and as adjusted or readjusted as provided
in this Warrant. The Company will forthwith mail a copy of each such certificate to the Holder and any warrant agent of the Company
(appointed pursuant to Section 12 hereof).

 

9.          Reservation
of Stock, Etc., Issuable on Exercise of Warrant. The Company shall at all times reserve and keep available out of its authorized
Common Stock, a number of shares of Common Stock equal to 200% of the full number of shares of Common Stock issuable solely for
issuance and delivery on the exercise of this Warrant.

 

10.       Assignment;
Exchange of Warrant. Subject to compliance with applicable securities laws, this Warrant, and the rights evidenced hereby,
may be transferred by any registered holder hereof (a “Transferor”) in whole or in part. On the surrender for
exchange of this Warrant, with the Transferor’s endorsement in the form of Exhibit B attached hereto (the “Transferor
Endorsement Form”) and together with evidence reasonably satisfactory to the Company demonstrating compliance with applicable
securities laws, which shall include, without limitation, a legal opinion from the Transferor’s counsel (at the Transferor’s
expense) that such transfer is exempt from the registration requirements of applicable securities laws, the Company at its expense
(but with payment by the Transferor of any applicable transfer taxes) will issue and deliver to or on the order of the Transferor
thereof a new Warrant of like tenor, in the name of the Transferor and/or the transferee(s) specified in such Transferor Endorsement
Form (each a “Transferee”), calling in the aggregate on the face or faces thereof for the number of shares of
Common Stock called for on the face or faces of the Warrant so surrendered by the Transferor.

 

11.       Replacement
of Warrant. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of any such loss, theft or destruction of this Warrant, on delivery of an indemnity agreement or
security reasonably satisfactory in form and amount to the Company or, in the case of any such mutilation, on surrender and cancellation
of this Warrant, the Company at its expense will execute and deliver, in lieu thereof, a new Warrant of like tenor.

 

12.       Warrant
Agent. The Company may, by written notice to the Holder of the Warrant, appoint an agent for the purpose of issuing Common
Stock (or Other Securities) on the exercise of this Warrant pursuant to Section 2, exchanging this Warrant pursuant to Section
9, and replacing this Warrant pursuant to Section 11, or any of the foregoing, and thereafter any such issuance, exchange or replacement,
as the case may be, shall be made at such office by such agent.

 

13.       Transfer
on the Company’s Books. Until this Warrant is transferred on the books of the Company, the Company may treat the registered
holder hereof as the absolute owner hereof for all purposes, notwithstanding any notice to the contrary.

 

    	 	Page 9 of 11	 

     

    

  

14.       Notices,
Etc. All notices and other communications from the Company to the Holder shall be mailed by first class registered or certified
mail, postage prepaid, at such address as may have been furnished to the Company in writing by such Holder or, until any such Holder
furnishes to the Company an address, then to, and at the address of, the last Holder who has so furnished an address to the Company.

 

15.       Holder
Not Deemed a Stockholder; Limitations on Liability. Except as otherwise specifically provided herein, prior to the issuance
to the Holder of the Common Stock to which the Holder is then entitled to receive upon the due exercise of this Warrant, the Holder
shall not be entitled to vote or receive dividends or be deemed the holder of shares of capital stock of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, as such, any of the rights of a stockholder
of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock,
reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription
rights, or otherwise. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder
to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities
are asserted by the Company or by creditors of the Company.

 

16.       Compliance
with the Securities Act. The Holder, by acceptance of this Warrant, agrees to comply in all respects with the provisions of
this Section 17 and the restrictive legend requirements set forth on the face of this warrant and further agrees that such Holder
shall not offer, sell or otherwise dispose of this Warrant or any Common Stock to be issued upon exercise hereof except under circumstances
that will not result in a violation of the Securities Act of 1933, as amended (the “Securities Act”).

 

17.       Miscellaneous.
This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the
party against which enforcement of such change, waiver, discharge or termination is sought. THIS WARRANT SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAWS. ANY ACTION BROUGHT
CONCERNING THE TRANSACTIONS CONTEMPLATED BY THIS WARRANT SHALL BE BROUGHT ONLY IN THE STATE COURTS OF NEW YORK OR IN THE FEDERAL
COURTS LOCATED IN THE STATE OF NEW YORK; PROVIDED, HOWEVER, THAT THE HOLDER MAY CHOOSE TO WAIVE THIS PROVISION AND BRING AN ACTION
OUTSIDE THE STATE OF NEW YORK. The individuals executing this Warrant on behalf of the Company agree to submit to the jurisdiction
of such courts and waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorneys’
fees and costs. In the event that any provision of this Warrant is invalid or unenforceable under any applicable statute or rule
of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified
to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not
affect the validity or enforceability of any other provision of this Warrant. The headings in this Warrant are for purposes of
reference only, and shall not limit or otherwise affect any of the terms hereof. The invalidity or unenforceability of any provision
hereof shall in no way affect the validity or enforceability of any other provision hereof. The Company acknowledges that legal
counsel participated in the preparation of this Warrant and, therefore, stipulates that the rule of construction that ambiguities
are to be resolved against the drafting party shall not be applied in the interpretation of this Warrant to favor any party against
the other party.

 

    	 	Page 10 of 11	 

     

    

 

[BALANCE OF PAGE INTENTIONALLY LEFT
BLANK;

SIGNATURE PAGE FOLLOWS]

 

    	 	Page 11 of 11	 

     

    

 

IN WITNESS WHEREOF,
the Company has executed this Warrant as of the date first written above.

 

	 	NUGENE INTERNATIONAL, INC.
	 	 	 
	 	By:	/s/ Ali Kharazmi
	 	Name:	Ali Kharazmi
	 	Title:	Chief Executive Officer

 

Signature Page to Warrant

 

     

     

    

 

EXHIBIT A

 

EXERCISE NOTICE

 

(To Be Signed Only On Exercise Of Warrant)

 

		TO:	NUGENE INTERNATIONAL, INC.

		Attention:	Chief Financial Officer

 

The undersigned, pursuant
to the provisions set forth in the attached Warrant (No.____) (as amended, restated or otherwise modified from time to time, the
“Warrant”; capitalized terms used but not defined in this notice shall have the meanings ascribed thereto in the Warrant),
hereby irrevocably elects to purchase (check applicable box):

 

		________	________ shares of the common stock covered by such warrant; or

 

		________	the maximum number of shares of common stock covered by such warrant pursuant to the cashless exercise
procedure set forth in Section 3.6.

 

The undersigned herewith
makes payment of the full Exercise Price for such shares at the price per share provided for in such Warrant, which is $___________.
Such payment takes the form of (check applicable box or boxes):

 

		________	$__________ in lawful money of the United States; and/or

 

		________	the cancellation of such portion of the attached Warrant as is exercisable for a total of _______
shares of Common Stock (using a Fair Market Value of $_______ per share for purposes of this calculation); and/or

 

		________	the cancellation of such number of shares of Common Stock as is necessary, in accordance with the
formula set forth in Section 3.6(c), to exercise this Warrant with respect to the maximum number of shares of Common Stock purchasable
pursuant to the cashless exercise procedure set forth in Section 3.6.

 

The undersigned
requests that the certificates for such shares be issued in the name of, and delivered to
______________________________________________ whose address is
___________________________________________________________________________.

 

The undersigned is
an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended. The undersigned
represents and warrants that all offers and sales by the undersigned of the securities issuable upon exercise of the within Warrant
shall be made pursuant to registration of the Common Stock under the Securities Act of 1933, as amended (the “Securities
Act”), or pursuant to an exemption from registration under the Securities Act.

 

	Dated:	
 	
	

	 	 	 	(Signature must conform to name of holder as specified on the face of the Warrant)
	 	 	 	Address:	

	 	 	 	 	
 

 

     

     

    

 

EXHIBIT B

 

FORM OF TRANSFEROR ENDORSEMENT

 

(To Be Signed Only On Transfer Of Warrant)

 

For value received,
the undersigned hereby sells, assigns, and transfers unto the person(s) named below under the heading “Transferees”
the right represented by the within Warrant to purchase the percentage and number of shares of Common Stock of NUGENE INTERNATIONAL,
INC. into which the within Warrant relates specified under the headings “Percentage Transferred” and “Number
Transferred,” respectively, opposite the name(s) of such person(s) and appoints each such person Attorney to transfer its
respective right on the books of NUGENE INTERNATIONAL, INC. with full power of substitution in the premises.

 

	Transferees	 	Address	 	Percentage 

Transferred	 	Number 

Transferred
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 

 

	Dated:	
 	 	
 
	 	 	 	(Signature must conform to name of holder as specified on the face of the Warrant)
	 	 	 	Address:	
 
	 	 	 	 	
 
	 	 	 	 	 
	 	 	 	SIGNED IN THE PRESENCE OF:
	 	 	 	 
	 	 	 	

	 	 	 	(Name)

 

	ACCEPTED AND AGREED:	 
	[TRANSFEREE]	 
	 	 
	 	 
	(Name)	 

 

NOTE: The signature to this Assignment Form must correspond
with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be
guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity
should file proper evidence of authority to assign the foregoing Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00252-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00252-of-00352.parquet"}]]